FSD1L
FSD1-like protein
Also known as: CCDC10, CSDUFD1, FSD1CL, FSD1L_HUMAN, FSD1NL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BXM9
- Gene
- FSD1L
- Ensembl
- ENSG00000106701
- Chromosome
- 9
- Canonical length
- 530 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus,Vesicles,Plasma membrane
OverviewNCBI Gene
Predicted to be located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
530 residues, UniProt reviewed canonical sequence.
>Q9BXM9|FSD1L
1 MDSQKYCFKE NENVTVDKAC FLISNITIGP ESINLQQEAL QRIISTLANK NDEIQNFIDT
61 LHHTLKGVQE NSSNILSELD EEFDSLYSIL DEVKESMINC IKQEQARKSQ ELQSQISQCN
121 NALENSEELL EFATRSLDIK EPEEFSKAAR QIKDRVTMAS AFRLSLKPKV SDNMTHLMVD
181 FSQERQMLQT LKFLPVPKAP EIDPVECLVA DNSVTVAWRM PEEDNKIDHF ILEHRKTNFD
241 GLPRVKDERC WEIIDNIKGT EYTLSGLKFD SKYMNFRVRA CNKAVAGEYS DPVTLETKAL
301 NFNLDNSSSH LNLKVEDTCV EWDPTGGKGQ ESKIKGKENK GRSGTPSPKR TSVGSRPPAV
361 RGSRDRFTGE SYTVLGDTAI ESGQHYWEVK AQKDCKSYSV GVAYKTLGKF DQLGKTNTSW
421 CIHVNNWLQN TFAAKHNNKV KALDVTVPEK IGVFCDFDGG QLSFYDANSK QLLYSFKTKF
481 TQPVLPGFMV WCGGLSLSTG MQVPSAVRTL QKSENGMTGS ASSLNNVVTQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FSD1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 40 nTPM
Expression across tissuesHPA
Tissue
- retina: 40 nTPM
- tongue: 12 nTPM
- spinal cord: 11 nTPM
- cerebral cortex: 11 nTPM
- hypothalamus: 7.9 nTPM
- midbrain: 7.1 nTPM
Single-cell type
- cone photoreceptor cells: 849 nCPM
- rod photoreceptor cells: 308 nCPM
- gonadotrophs: 233 nCPM
- ependymal cells: 214 nCPM
- respiratory ciliated cells: 161 nCPM
- fallopian tube ciliated cells: 149 nCPM
Immune cell
- memory B-cell: 1.8 nTPM
- classical monocyte: 0.9 nTPM
- memory CD4 T-cell: 0.7 nTPM
- naive B-cell: 0.7 nTPM
- intermediate monocyte: 0.6 nTPM
- myeloid DC: 0.6 nTPM
Brain region
- medulla oblongata: 45 nTPM
- hypothalamus: 42 nTPM
- spinal cord: 41 nTPM
- pons: 40 nTPM
- white matter: 40 nTPM
- midbrain: 40 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FSD1L.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 66 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.48
- gnomAD pLI
- 0.23
- gnomAD missense Z
- 1.52
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
Protein domainsUniProt · Pfam · InterPro
- B30.2/SPRY domain
- B-box, C-terminal
- SPRY domain
- Butyrophylin-like, SPRY domain
- Fibronectin type III
- Concanavalin A-like lectin/glucanase domain superfamily
- Immunoglobulin-like fold
- COS domain
- Fibronectin type III and SPRY containing 1, PRY/SPRY domain
- Fibronectin type III superfamily
- B30.2/SPRY domain superfamily
- E3 ubiquitin-protein ligases and FN3/SPRY domain-containing proteins
- Fibronectin type III domain
- SPRY domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FSD1L as an antibody target. Whether an autoantibody or antibody against FSD1L could matter depends on whether native FSD1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FSD1L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FSD1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...